Rev Genomics
Company Overview
I was the co-founder and VP of Genomics and led the technical aspects of Rev Genomics from idea to post series-A (2015-2020). I led, designed and implemented a probabilistic framework to elucidate novel biochemical pathways in Cannabis. Under my leadership my team built a data driven Cannabis breeding pipeline using genomic prediction leading to 15+ commercial strains being developed for the legal California market. Notable investors for Rev Genomics are Y-Combinator and Gron Ventures.
Open Cannabis SNP Map Dataset
As part of my work at Rev Genomics, I analyzed and generated a dataset of 23500+ SNP and 2200+ InDel molecular markers from 1358 cultivars of Cannabis to aid in open-source breeding projects. The project contains data and tutorial on how to view and use the data using open-source tools. The data and tutorial are licensed under Creative Commons Attributions License 4.0 and can be downloaded directly here (500MB). An accompanying article was published on the Future Cannabis Project Blog.
Rev Genomics continues in innovate in the Cannabis biotechnology space.